Ascend Study - Home

If You Suffer from Migraine, Can You Honestly Say that You are Satisfied with Your Current Treatment?

The Ascend Study is evaluating a new investigational treatment for migraine.

Your migraine doesn’t have to keep you in the dark. Consider the ASCEND Study today.

You may be able to participate in the ASCEND Study if YOU:

The investigational medication is taken as powder that is administered into your nose.

You will receive all study-related care at no cost.  Health insurance is not needed.

About Migraine

Migraine is a common, but incapacitating, neurological disease that affects approximately 39 million people in the United States alone.

Migraine is the

3rd

most prevalent illness in the world

Migraine typically involves a severe throbbing recurring pain, usually on one side of the head.

Migraine is most common between the ages of 25 and 55.

About

0 %

of migraine sufferers have a family history of migraine.

Attacks are often accompanied by one of more of the following: nausea, vomiting, extreme sensitivity to sound, light, touch and smell, and tingling or numbness of the extremities of face.

Attacks usually last between 4 and 72 hours.

There is still so much research that needs to be done so better treatments can come to the market. This is where the ASCEND Study comes in.

Source: migraineresearchfoundation.org

The ASCEND Study is evaluating a new investigational treatment option for migraine pain.

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.